Page 19 - 76_04

VOL. 76 (4), 459-478, 2010 INNOVATION VS. TRADITION: THE ELECTION…

gelatine capsules and the amylaceous capsules disappeared from the
therapeutic map. Only the injectable vials, due to the hybridisation of
technologies between both models, have been able to survive.

The ‘innovative’ model: The ‘traditional’ model:
Centro-European area European-Mediterranean area

• Countries: Germany, England, • Countries; France, Spain, Italy.
Switzerland.

• Basic chemical industry very devel- • Chemical industry little developed and

oped, especially organic ones. the organic even less.

• Highly capitalised firms and with great • Few highly capitalised firms and abun-

quantity of labour. dance of labour.

• Inclusion of highly qualified salaried • Deficient training in industrial chemis-

personnel. try: lack of qualified personnel.

• Clear separation between the property • Tendency towards inter-professional
(limited companies) and the technical capitalisations: pharmaceutical capi-
management. tal. Separation between the owner of
the productive centre and the techni-
cal management did not exist.

• Integrated chemical industry: manufac- • Typical industry of consumer goods: ex-
ture of dyestuffs, explosives photogra- clusive manufacture of drugs. Inexis-
phic material, perfumes and medicines. tence of a global industrial organigram.

• Inexistence of a pharmaceutical indus- • Pharmaceutical industry with own
try with own identity. Exception: the in- identity. Place of manufacture: dispen-
dustry based on vegetable active prin- saries, dependent and independent
ciples. laboratories.

• The essential of the drug is its active • The ‘covering’ of the drug is the pri-
pharmacological molecule; pharma- mordial aim, the active pharmacolog-
ceutical form, the finished product, is ical substances are no more than raw
no more than a covering. materials.

• The execution of the hegemony through • Industrial protection is effected through
the industrial property: manufacturers the trademark of the establishment or
brand marks for the chemical sub- pharmaceutical speciality.
stances.

• Secondary role of the pharmaceutical • The pharmaceutical is the protagonist
in the global industrialisation process. of the industrialising process.
Principle protagonists: the investors
and chemical engineers.

475